September 11, 2024 Maria Dranishnikova Best-selling drugs in pill form: How Lexaria plans to make it big on weight-loss wave
September 10, 2024 Maria Dranishnikova Shares of pre-prepared food maker Mama’s Creations rise after new COO announced
September 9, 2024 Maria Dranishnikova Zacks spotlights three stocks poised to benefit from booming tech services market
September 9, 2024 Maria Dranishnikova Satellite communication systems maker SatixFy halves net loss in first half
September 6, 2024 Maria Dranishnikova Citius Oncology stock jumps after its drug included in clinical guidelines
September 6, 2024 Maria Dranishnikova Amazon for patriots: How PSQ Holdings is monetizing Trump campaign slogans
September 5, 2024 Maria Dranishnikova Display manufacturer Daktronics retreats after first-quarter financials
September 5, 2024 Maria Dranishnikova Athira stock plummets after its Alzheimer’s treatment fails in trials
September 4, 2024 Maria Dranishnikova Eyewear retailer KITS upgrades revenue guidance after strong August
September 4, 2024 Maria Dranishnikova Less-lethal weapons maker Byrna preliminarily reports 200% revenue growth, stock soars
September 4, 2024 Maria Dranishnikova Haypp could lose 20% of sales in Stockholm city crackdown on snus
September 3, 2024 Maria Dranishnikova Barchart.com contributor fingers small AI company with 79% upside
September 3, 2024 Maria Dranishnikova Insider Monkey names seven AI penny stocks most popular with hedge funds
September 2, 2024 Maria Dranishnikova Zacks spotlights cancer and sepsis test developer VolitionRx as undervalued
August 30, 2024 Maria Dranishnikova Value of company developing kidney disease treatments doubles in one day
August 29, 2024 Maria Dranishnikova Small caps and the U.S. election: How investors can win in the home stretch
August 29, 2024 Maria Dranishnikova Byrna shares rise after Uruguay buys its less-lethal launchers, ammunition
August 28, 2024 Maria Dranishnikova Pharmaceutical company Sonoma slides after reverse stock split announced
August 27, 2024 Maria Dranishnikova Vaping addiction treatment developer changes CEO, possibly ahead of sale
August 27, 2024 Maria Dranishnikova Simply Wall St recommends three dividend stocks for investors seeking stability